ES2721848T3 - Probióticos para su uso en la prevención primaria de enfermedades atópicas - Google Patents
Probióticos para su uso en la prevención primaria de enfermedades atópicas Download PDFInfo
- Publication number
- ES2721848T3 ES2721848T3 ES09164285T ES09164285T ES2721848T3 ES 2721848 T3 ES2721848 T3 ES 2721848T3 ES 09164285 T ES09164285 T ES 09164285T ES 09164285 T ES09164285 T ES 09164285T ES 2721848 T3 ES2721848 T3 ES 2721848T3
- Authority
- ES
- Spain
- Prior art keywords
- atopic diseases
- probiotics
- primary prevention
- atopic
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/853—Lactobacillus
- Y10S435/856—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Bacterias probióticas, que tienen las características de promover la microflora bifidogénica intestinal temprana, para su uso en un método para la prevención primaria de enfermedades atópicas en un niño en alto riesgo de enfermedades atópicas, en donde las bacterias probióticas se administran a una mujer embarazada durante al menos dos semanas antes del alumbramiento y después del alumbramiento, al niño recién nacido durante al menos 2 meses.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20001460A FI110668B (fi) | 2000-06-20 | 2000-06-20 | Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2721848T3 true ES2721848T3 (es) | 2019-08-05 |
Family
ID=8558595
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09164285T Expired - Lifetime ES2721848T3 (es) | 2000-06-20 | 2001-06-20 | Probióticos para su uso en la prevención primaria de enfermedades atópicas |
ES01951716T Expired - Lifetime ES2329549T3 (es) | 2000-06-20 | 2001-06-20 | Probioticos para la prevencion primaria de enfermedades atopicas. |
ES09164284T Expired - Lifetime ES2754797T3 (es) | 2000-06-20 | 2001-06-20 | Bifidobacterium lactis Bb-12 en prevención primaria de enfermedades atópicas |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES01951716T Expired - Lifetime ES2329549T3 (es) | 2000-06-20 | 2001-06-20 | Probioticos para la prevencion primaria de enfermedades atopicas. |
ES09164284T Expired - Lifetime ES2754797T3 (es) | 2000-06-20 | 2001-06-20 | Bifidobacterium lactis Bb-12 en prevención primaria de enfermedades atópicas |
Country Status (9)
Country | Link |
---|---|
US (2) | US7112322B2 (es) |
EP (3) | EP1296694B1 (es) |
AT (1) | ATE439138T1 (es) |
AU (1) | AU784921B2 (es) |
DE (2) | DE60139554D1 (es) |
ES (3) | ES2721848T3 (es) |
FI (1) | FI110668B (es) |
PT (2) | PT2201955T (es) |
WO (1) | WO2001097822A1 (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1364586A1 (en) * | 2002-05-24 | 2003-11-26 | Nestec S.A. | Probiotics and oral tolerance |
JP4212838B2 (ja) | 2002-06-26 | 2009-01-21 | カルピス株式会社 | 抗アレルギー剤 |
WO2005058335A1 (en) | 2003-12-17 | 2005-06-30 | N.V. Nutricia | Lactic acid producing bacteria and lung function |
US7955834B2 (en) | 2004-06-03 | 2011-06-07 | Biogaia Ab | Method for improved breast milk feeding to reduce the risk of allergy |
US7862808B2 (en) | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
EP1731137A1 (fr) * | 2005-06-08 | 2006-12-13 | Nestec S.A. | Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles |
EP1642570A1 (fr) | 2004-10-04 | 2006-04-05 | L'oreal | Composition cosmétique et/ou dermatologique pour peaux sensibles |
FR2876029B1 (fr) * | 2004-10-04 | 2008-11-14 | Oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles. |
WO2006037922A1 (fr) * | 2004-10-04 | 2006-04-13 | L'oreal | Composition cosmetique et/ou dermatologique pour peaux sensibles |
ITMI20042189A1 (it) * | 2004-11-16 | 2005-02-16 | Anidral Srl | Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale |
RU2270248C1 (ru) * | 2004-12-31 | 2006-02-20 | Открытое акционерное общество "Лианозовский молочный комбинат" | Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств |
US7303745B2 (en) | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
US8021883B2 (en) | 2005-05-11 | 2011-09-20 | Chr. Hansen A/S | Antibiotic-sensitive lactic acid bacteria strains |
JP2009067679A (ja) * | 2005-12-27 | 2009-04-02 | Univ Of Tokushima | 抗ヒスタミン作用を有する医薬 |
CA2645472C (en) | 2006-03-10 | 2015-09-15 | N.V. Nutricia | Use of non-digestable saccharides for giving an infant the best start after birth |
US8226936B2 (en) | 2006-11-15 | 2012-07-24 | Chr-Hansen A/S | Tetracycline-sensitive bifidobacteria strains |
WO2008071930A1 (en) | 2006-12-11 | 2008-06-19 | Danisco A/S | Composition |
BRPI0721254A2 (pt) * | 2007-02-22 | 2013-01-15 | Juergen Schrezenmeir | medicamento para a profilaxia, supressço ou eliminaÇço de reaÇÕes alÉrgicas, medicamento para a troca de balanÇo th1-th2 no corpo humano em direÇço a uma aumento de th1 e/ou a reduÇço de th2, mÉtodo para o preparo de um medicamento para a profilaxia, supressço ou eliminaÇço de reaÇÕes alÉrgicas em humanos, mÉtodo para a produÇço de um medicamento para a troca de balanÇo th1-th2 no corpo humano em direÇço a um aumento de th1 e/ou a uma reduÇço de th2, uso de bactÉria gram-positiva, probiàtica tais como, lactobacilos e bifidobactÈria, e alimento ou suplemento de alimento |
CN101273736B (zh) * | 2007-03-28 | 2012-08-08 | 北京弗蒙特生物技术有限公司 | 一种在常温下保持高活菌数的发酵乳的制备方法 |
EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
US20090007924A1 (en) * | 2007-04-30 | 2009-01-08 | Iliff Edwin C | Arbiter system and method of computerized medical diagnosis and advice |
FR2920305B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
FR2920304B1 (fr) | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
CA2719719A1 (en) | 2008-03-28 | 2009-10-01 | Nestec S.A. | Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings |
US20110053889A1 (en) * | 2008-09-02 | 2011-03-03 | Joanne Szabo | Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function |
FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
CA2774963A1 (en) * | 2009-10-09 | 2011-04-14 | Prothera, Inc. | Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
CN102269858A (zh) | 2010-06-02 | 2011-12-07 | 北京智朗芯光科技有限公司 | 自动聚焦系统和自动聚焦方法 |
WO2012000959A1 (en) * | 2010-06-30 | 2012-01-05 | Nestec S.A. | Use of caftaric acid and lactic bacterium in food or beverages for regulating skin pigmentation |
MY171620A (en) | 2010-12-31 | 2019-10-21 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides |
NZ612504A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
EE05721B1 (et) | 2011-02-25 | 2014-08-15 | OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus | Isoleeritud mikroorganismi tüvi L. plantarum MCC1 DSM 23881 ja selle kasutamine |
EP2510932A1 (en) | 2011-04-15 | 2012-10-17 | Nestec S.A. | Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny |
US10039296B2 (en) | 2011-06-20 | 2018-08-07 | H.J. Heinz Company Brands Llc | Probiotic compositions and methods |
US11446316B2 (en) | 2011-07-22 | 2022-09-20 | Abbott Laboratories | Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
CN113662199A (zh) | 2011-08-29 | 2021-11-19 | 雅培制药有限公司 | 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖 |
EP2617296A1 (en) * | 2012-01-19 | 2013-07-24 | Nestec S.A. | A composition comprising specific Lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms |
CN110201003A (zh) | 2012-02-29 | 2019-09-06 | 伊西康内外科公司 | 微生物区系的组合物及与其相关的方法 |
DK2861242T3 (en) | 2012-06-18 | 2018-10-29 | Heinz Co Brands H J Llc | GLUTEN RELATED DISORDERS |
WO2014052438A1 (en) | 2012-09-25 | 2014-04-03 | Regents Of The University Of Minnesota | Methods for making and using antimicrobial peptides |
PL2994150T3 (pl) | 2013-05-10 | 2019-09-30 | H.J. Heinz Company Brands Llc | Probiotyki i sposoby zastosowania |
US20150064304A1 (en) * | 2013-09-03 | 2015-03-05 | Mario Medri | Probiotic lozenge, method of making same, and uses thereof |
MX2016005408A (es) * | 2013-11-15 | 2016-08-11 | Nestec Sa | Ficomposiciones para prevenir o tratar alergias en infantes a partir de o alimentados por madres no secretoras mediante el suministro de oligosacaridos fucosilados, particularmente entre los niños en riesgo o nacidos por cesarea. |
WO2015090349A1 (en) | 2013-12-16 | 2015-06-25 | Nestec S.A. | Probiotic nutritional intervention during pregnancy and optionally lactation to reduce risk of allergy in infants |
EP2886660A1 (en) * | 2013-12-20 | 2015-06-24 | Rigas Tehniska universitate | A fluorescent in situ hybridization method for identification of a microorganism |
SG10201903823QA (en) | 2014-10-31 | 2019-05-30 | Whole Biome Inc | Methods and compositions relating to microbial treatment and diagnosis of disorders |
US20160271189A1 (en) * | 2015-03-18 | 2016-09-22 | Whole Biome, Inc. | Methods and compositions relating to microbial treatment and diagnosis of skin disorders |
CA2950839C (en) * | 2016-01-30 | 2023-09-12 | Cooper Technologies Company | Equipment rack and components thereof |
WO2019046646A1 (en) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS |
US20220000947A1 (en) * | 2018-12-21 | 2022-01-06 | Société des Produits Nestlé S.A. | Probiotic combination for treatment of allergic disorders |
WO2021138599A1 (en) * | 2020-01-03 | 2021-07-08 | Forte Subsidiary, Inc. | Cosmetic compositions |
MX2023006086A (es) * | 2020-11-24 | 2023-08-07 | Johnson & Johnson Consumer Inc | Métodos para prevenir, retrasar o aliviar enfermedades atópicas. |
WO2024042229A1 (en) | 2022-08-25 | 2024-02-29 | Chr. Hansen A/S | Bifidobacterium strains with improved stability |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591446A (en) * | 1989-04-04 | 1997-01-07 | Beiersdorf, A.G. | Methods and agents for the prophylaxis of atopy |
US5246591A (en) * | 1990-07-13 | 1993-09-21 | Pact, Incorporated | Separation of metal ions on an anion exchange resin by chromatographic elution |
BE1009359A7 (fr) * | 1995-05-19 | 1997-02-04 | Univ Bruxelles | Procede de detection et/ou de quantification de ligands specifiques d'une pathologie liee a une reponse allergique. |
FI104465B (fi) * | 1995-06-14 | 2000-02-15 | Valio Oy | Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö |
EP0904784A1 (en) * | 1997-09-22 | 1999-03-31 | N.V. Nutricia | Probiotic nutritional preparation |
GB9808579D0 (en) | 1998-04-22 | 1998-06-24 | Novartis Nutrition Ag | Improvements in or relating to organic compounds |
JP4010062B2 (ja) * | 1998-09-02 | 2007-11-21 | 医療法人社団青藍会 | アトピー性皮膚炎を防ぐ保健食品 |
JP2000086524A (ja) | 1998-09-05 | 2000-03-28 | Shadan Seirankai | 生きた腸内細菌を含有する抗アレルギー剤 |
AUPQ415899A0 (en) * | 1999-11-19 | 1999-12-16 | Vasse Research Institute Pty Ltd | Compositions for and methods of treatment of allergic diseases |
-
2000
- 2000-06-20 FI FI20001460A patent/FI110668B/fi active
-
2001
- 2001-06-20 PT PT91642843T patent/PT2201955T/pt unknown
- 2001-06-20 ES ES09164285T patent/ES2721848T3/es not_active Expired - Lifetime
- 2001-06-20 AU AU72572/01A patent/AU784921B2/en not_active Expired
- 2001-06-20 EP EP01951716A patent/EP1296694B1/en not_active Expired - Lifetime
- 2001-06-20 US US10/311,706 patent/US7112322B2/en not_active Expired - Lifetime
- 2001-06-20 ES ES01951716T patent/ES2329549T3/es not_active Expired - Lifetime
- 2001-06-20 AT AT01951716T patent/ATE439138T1/de not_active IP Right Cessation
- 2001-06-20 PT PT01951716T patent/PT1296694E/pt unknown
- 2001-06-20 DE DE60139554T patent/DE60139554D1/de not_active Expired - Lifetime
- 2001-06-20 EP EP09164285.0A patent/EP2206507B1/en not_active Expired - Lifetime
- 2001-06-20 WO PCT/FI2001/000588 patent/WO2001097822A1/en active Application Filing
- 2001-06-20 DE DE01951716T patent/DE01951716T1/de active Pending
- 2001-06-20 EP EP09164284.3A patent/EP2201955B1/en not_active Expired - Lifetime
- 2001-06-20 ES ES09164284T patent/ES2754797T3/es not_active Expired - Lifetime
-
2005
- 2005-09-14 US US11/225,204 patent/US7988960B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT2201955T (pt) | 2019-11-25 |
PT1296694E (pt) | 2009-10-28 |
FI20001460A (fi) | 2001-12-21 |
DE60139554D1 (de) | 2009-09-24 |
FI20001460A0 (fi) | 2000-06-20 |
ES2754797T3 (es) | 2020-04-20 |
ES2329549T3 (es) | 2009-11-27 |
EP1296694A1 (en) | 2003-04-02 |
WO2001097822A1 (en) | 2001-12-27 |
ATE439138T1 (de) | 2009-08-15 |
US20030180272A1 (en) | 2003-09-25 |
EP2206507A1 (en) | 2010-07-14 |
AU784921B2 (en) | 2006-07-27 |
AU7257201A (en) | 2002-01-02 |
DE01951716T1 (de) | 2005-06-23 |
EP2206507B1 (en) | 2019-03-13 |
FI110668B (fi) | 2003-03-14 |
US20060013806A1 (en) | 2006-01-19 |
US7988960B2 (en) | 2011-08-02 |
EP2201955A1 (en) | 2010-06-30 |
EP1296694B1 (en) | 2009-08-12 |
EP2201955B1 (en) | 2019-08-14 |
US7112322B2 (en) | 2006-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2721848T3 (es) | Probióticos para su uso en la prevención primaria de enfermedades atópicas | |
ATE302265T1 (de) | Einen lactobacillus-stamm enthaltende zusammensetzung und verwendungen davon | |
BR9916062A (pt) | Administração oral de lactobacillus para o tratamento e prevenção de infecção urogenital | |
HK1081432A1 (en) | Antiallergic agent, utilization thereof in the manufacture of a medicament for reducing allergy | |
BRPI0416292A (pt) | composições estabilizadas compreendendo probióticos | |
ATE551063T1 (de) | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen | |
DE602004006133D1 (de) | Neue galactooligosaccharidzusammensetzung und herstellung davon | |
ATE421256T1 (de) | Probiotische zusammensetzung | |
NO20061736L (no) | Krystallform av epotilon B | |
DE60226254D1 (de) | Milchsäureproduzierende bakterien zur verwendung als probiotische organismen in der menschlichen scheide | |
TW200603746A (en) | Iron sulfate based phosphate adsorbent | |
ZA200104931B (en) | Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body. | |
ATE464045T1 (de) | Zusammensetzung aus milchsäure und lactoferrin | |
BR0015698A (pt) | Composições e métodos para tratamento de doenças alérgicas | |
DK1675603T3 (da) | Anvendelse af probiotiske bakterier i behandling af infektion | |
BR0209541A (pt) | Uso das imidazotriazinonas 2-fenil-substituìdas | |
WO2005005481A3 (en) | Combination therapy for gastroenteric diseases caused by microorganisms | |
ATE455789T1 (de) | Substituierte nonadepsipeptide | |
DE69927930D1 (de) | Zusammensetzung geeignet als Nahrungsmittelzusatz und zur Anwendung bei Darmerkrankungen sowie bei veränderter Darmflora | |
ATE333875T1 (de) | Pharmazeutische zubereitungen die sojaisoflavonsextrakte und probiotische mikroorganismen enthalten | |
EE200300220A (et) | Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod | |
UY27475A1 (es) | Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización | |
RU2002103078A (ru) | Способ профилактики диарейных болезней новорожденных телят и поросят | |
UA10887U (uk) | Спосіб профілактики бронхолегеневих захворювань у дітей, які народились в сім'ях ліквідаторів аварії на чаес |